Candida auris in US Correctional Facilities

被引：2

作者：

Hennessee, Ian ^{[1
]}

Forsberg, Kaitlin ^{[1
]}

Erskine, Jalysa ^{[2
]}

Charles, Argentina ^{[2
]}

Russell, Barbara ^{[2
]}

Reyes, Juliana ^{[2
]}

Emery, Chantel ^{[2
]}

Valencia, Nickolas ^{[2
]}

Sherman, Adrienne ^{[3
]}

Mehr, Jason ^{[3
]}

Gallion, Hannah ^{[4
]}

Halleck, Brandon ^{[4
]}

Cox, Caleb ^{[4
]}

Bryant, Marcie ^{[4
]}

Nichols, Deborah ^{[5
]}

Medrzycki, Magdalena ^{[1
]}

Ham, D. Cal ^{[1
]}

Hagan, Liesl M. ^{[1
]}

Lyman, Meghan ^{[1
]}

机构：

[1] CDCP, 1600 Clifton Rd NE,Mailstop H24-10, Atlanta, GA 30329 USA

[2] Florida Dept Hlth, Tallahassee, FL USA

[3] New Jersey Dept Hlth, Trenton, NJ USA

[4] Indiana Dept Hlth, Indianapolis, IN USA

[5] Indiana Dept Correct, Indianapolis, IN USA

来源：

EMERGING INFECTIOUS DISEASES | 2024年 / 30卷 / 13期

关键词：

D O I：

10.3201/eid3013.230860

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Candida auris is an emerging fungal pathogen that typically affects patients in healthcare settings. Data on C. auris cases in correctional facilities are limited but are needed to guide public health recommendations. We describe cases and challenges of providing care for 13 patients who were transferred to correctional facilities during January 2020- December 2022 after having a positive C. auris specimen. All patients had positive specimens identified while receiving inpatient care at healthcare facilities in geographic areas with high C. auris prevalence. Correctional facilities reported challenges managing patients and implementing prevention measures; those challenges varied by whether patients were housed in prison medical units or general population units. Although rarely reported, C. auris cases in persons who are incarcerated may occur, particularly in persons with known risk factors. Measures to manage cases and prevent C. auris spread in correctional facilities should address setting-specific challenges in healthcare and nonhealthcare correctional environments.

引用

页码：S36 / S40

页数：5

共 50 条

[1] Candida auris in skilled nursing facilities
Yune, Philip S. S.
Coe, Jared
Rao, Mana
Lin, Michael Y. Y.
THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2023, 10
[2] Susceptibility of Candida auris and Candida albicans to 21 germicides used in healthcare facilities
Rutala, William A.
Kanamori, Hajime
Gergen, Maria F.
Sickbert-Bennett, Emily E.
Weber, David J.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2019, 40 (03): : 380 - 382
[3] Candida auris: A Mini Review on Epidemiology in Healthcare Facilities in Asia
Thatchanamoorthy, Nishanthinie
Rukumani Devi, Velayuthan
Chandramathi, Samudi
Tay, Sun Tee
JOURNAL OF FUNGI, 2022, 8 (11)
[4] Infection Control Measures against Candida auris in Healthcare Facilities
Alfouzan, Wadha A.
Dhar, Rita
Alabbad, Jasim
Rabaan, Ali A.
PROCESSES, 2022, 10 (08)
[5] The catch 22 of condoms in US correctional facilities
Tucker, Joseph D.
Chang, Suzanne W.
Tulsky, Jacqueline P.
BMC PUBLIC HEALTH, 2007, 7 (1)
[6] The catch 22 of condoms in US correctional facilities
Joseph D Tucker
Suzanne W Chang
Jacqueline P Tulsky
BMC Public Health, 7
[7] Candida auris in the US Department of Veterans' Affairs (VA)
Lucero-Obusan, Cynthia
Schirmer, Patricia
Oda, Gina
Holodniy, Mark
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 : S146 - S146
[8] Hospital transmitted Candida auris infections confirmed in the US
McCarthy, Michael
BMJ-BRITISH MEDICAL JOURNAL, 2016, 355
[9] Environmental Surfaces in Healthcare Facilities are a Potential Source for Transmission of Candida auris and Other Candida Species
Piedrahita, Christina T.
Cadnum, Jennifer L.
Jencson, Annette L.
Shaikh, Aaron A.
Ghannoum, Mahmoud A.
Donskey, Curtis J.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2017, 38 (09): : 1107 - 1109
[10] Access to clozapine revisited: US correctional facilities and the law
Mason, SE
SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 346 - 346

← 1 2 3 4 5 →